Biophytis (EPA:ALBPS) | WebDisclosure

REGULATED PRESS RELEASE

published on 05/15/2025 at 07:00, 10 months 7 days ago

Biophytis Highlights Innovative Approach to Obesity Treatment During Key ECO 2025 Presentation
Biophytis highlights innovative approach to obesity treatment at ECO 2025 presentation, showcasing promising results of BIO101 drug candidate targeting muscle loss in obese patients

Biophytis Obesity Treatment BIO101 ECO 2025 Muscle Loss
REGULATED PRESS RELEASE

published on 05/15/2025 at 07:00, 10 months 7 days ago

Biophytis met en lumière son approche innovante du traitement de l’obésité lors d’une présentation majeure au congrès ECO 2025
Biophytis met en lumière son approche innovante du traitement de l'obésité lors d'une présentation majeure au congrès ECO 2025. Le Dr Serge Camelo présente les dernières données du programme clinique OBA sur BIO101 pour limiter la perte musculaire chez les patients obèses

Biophytis Traitement BIO101 Obésité Congrès ECO 2025
BRIEF

published on 04/25/2025 at 18:05, 10 months 27 days ago

Report de la publication des comptes annuels de Biophytis

Biophytis Biotechnologie Comptes Annuels Refinancement Publication Retardée
BRIEF

published on 04/25/2025 at 18:05, 10 months 27 days ago

Biophytis Delays Release of 2024 Financial Statements

Financial Statements Biophytis Refinancing 2024 Delay
REGULATED PRESS RELEASE

published on 04/25/2025 at 18:00, 10 months 27 days ago

Report de la publication des comptes annuels
Biophytis SA annonce le report de la publication de ses comptes annuels, clos le 31 décembre 2024, en raison d'un refinancement de 2,6 millions d'euros. La Société met tout en œuvre pour finaliser et publier ses états financiers avant fin mai 2025

États Financiers Comptes Annuels Report Refinancement Biophytis SA
REGULATED PRESS RELEASE

published on 04/25/2025 at 18:00, 10 months 27 days ago

Postponement of the publication of the annual financial statements
Biophytis announces postponement of annual financial statements publication due to refinancing operation. Company aims to release by end of May 2025

Financial Statements Biophytis 2024 Postponement Refinancing Operation
BRIEF

published on 04/22/2025 at 07:05, 11 months ago

Biophytis Aims for Enhanced Mobility in Obesity Treatment

Biophytis Obesity Treatment Muscle Preservation GLP-1 Therapies Biotechnology Market
BRIEF

published on 04/22/2025 at 07:05, 11 months ago

Biophytis et son avancée dans le traitement de l'obésité

Biophytis Marché Mondial Obésité GLP-1 Masse Musculaire
REGULATED PRESS RELEASE

published on 04/22/2025 at 07:00, 11 months ago

Biophytis targets mobility restoration in patients with obesity
Biophytis strengthens position in developing treatments for age-related muscle function loss in obesity care by focusing on quality weight loss and mobility restoration with BIO101 and GLP-1 therapies

Biophytis Muscle Function Obesity Care Quality Weight Loss Mobility Restoration
REGULATED PRESS RELEASE

published on 04/22/2025 at 07:00, 11 months ago

Biophytis cible la restauration de la mobilité chez les patients obèses
Biophytis développe des traitements pour restaurer la mobilité des patients obèses. Leur candidat-médicament BIO101, combiné avec GLP-1, améliore la force musculaire. Vers une nouvelle génération de thérapies axées sur la qualité de la perte de poids

Biophytis Mobilite BIO101 Obésité GLP-1

Published on 03/23/2026 at 02:00, 4 hours 29 minutes ago

FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 23:00, 2 days 7 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days 8 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days 9 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 16 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock

View all ACCESSWIRE

Published on 03/23/2026 at 03:35, 2 hours 54 minutes ago

Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 18:22, 12 hours 7 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 18 hours 6 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 7 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 9 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications

View all EQS

Published on 03/20/2026 at 19:00, 2 days 11 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 11 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 12 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 12 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days 12 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News